Company intelligence / Profile preview

OMNII Oral Pharmaceuticals

West Palm Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

OMNII Oral Pharmaceuticals was a specialized pharmaceutical and dental products company focused on preventive dentistry and oral health. The company was a market leader in providing professional-grade fluoride varnishes, gels, and antimicrobial rinses used by dental professionals to treat gingivitis and prevent tooth decay. Its most prominent product was Peridex (chlorhexidine gluconate 0.12%), a gold-standard prescription oral rinse for the treatment of gingivitis. In 2006, OMNII was acquired by 3M and integrated into its 3M ESPE dental division, which significantly bolstered 3M's portfolio in the preventive oral care market.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: Small moleculeTopical formulation
Industry: Biotech

Beyond the preview

Go deeper on OMNII Oral Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMNII Oral Pharmaceuticals.

Explore the full profile